Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

money business cash flow dollar

Boston Scientific invests $1.5B in MiRus with option to buy its TAVR business

Boston Scientific has invested heavily in Georgia-based MiRus, a rising name in the competitive TAVR landscape.

Acist Pro Diagnostic System from ACIST Medical Systems/Bracco

FDA clears next-gen contrast management system for the cath lab

The Acist Pro Diagnostic System provides real-time contrast tracking, customizable presets and on-screen troubleshooting.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Cardiologists are first in world to use new leaflet-splitting technique during TAVR

Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.

Shockwave C2 Aero Coronary IVL Catheter from Shockwave Medical

J&J launches Shockwave Medical’s next-generation coronary IVL catheter

The Shockwave C2 Aero Coronary IVL Catheter is based on years of user feedback. For example, it was built with improved deliverability and repositioning capabilities in mind.

prescription drugs

Routine testing is needed to locate patients who may not benefit from clopidogrel

Up to 30% of U.S. patients carry genetic variations that reduce the effectiveness of clopidogrel, an antiplatelet medication sold under the brand name Plavix.

Thumbnail

Is TAVR too common among younger patients? New data prompt a ‘call to action’

Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

SCAI is inviting younger female interventional cardiologists and fellows within five years of training to participate in the WONDER (Women Exposed to Occupational Doses of Radiation) study.

SCAI seeks female interventional cardiologists for radiation risk study

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic. 

KardiaPSI Balloon Catheter Corvention

FDA clears high-pressure balloon catheter for BAV procedures

The new device from Arizona-based Corvention was built to withstand the extreme pressures associated with treating severely calcified valves.